Abstract:A principal goal of drug discovery project is to design molecules that can tightly and selectively bind to the target protein receptor. Accurate prediction of protein-ligand binding free energies is therefore of central importance in computational chemistry and computer aided drug design. Multiple recent improvements in computing power, classical force field accuracy, enhanced sampling methods, and simulation setup have enabled accurate and reliable calculations of protein-ligands binding free energies, and position free energy calculations to play a guiding role in small molecule drug discovery. In this Account, we outline the relevant methodological advances, including the REST2 (Replica Exchange with Solute Temperting) enhanced sampling, the incorporation of REST2 sampling with convential FEP (Free Energy Perturbation) through FEP/REST, the OPLS3 force field, and the advanced simulation setup that constitute our FEP+ approach, followed by the presentation of extensive comparisons with experiment, demonstrating sufficient accuracy in potency prediction (better than 1 kcal/mol) to substantially impact lead optimization campaigns. The limitations of the current FEP+ implementation and best practices in drug discovery applications are also discussed followed by the future methodology development plans to address those limitations. We then report results from a recent drug discovery project, in which several thousand FEP+ calculations were successfully deployed to simultaneously optimize potency, selectivity, and solubility, illustrating the power of the approach to solve challenging drug design problems. The capabilities of free energy calculations to accurately predict potency and selectivity have led to the advance of ongoing drug discovery projects, in challenging situations where alternative approaches would have great difficulties. The ability to effectively carry out projects evaluating tens of thousands, or hundreds of thousands, of proposed drug candidates, is potentially transformative in enabling hard to drug targets to be attacked, and in facilitating the development of superior compounds, in various dimensions, for a wide range of targets. More effective integration of FEP+ calculations into the drug discovery process will ensure that the results are deployed in an optimal fashion for yielding the best possible compounds entering the clinic; this is where the greatest payoff is in the exploitation of computer driven design capabilities. A key conclusion from the work described is the surprisingly robust and accurate results that are attainable within the conventional classical simulation, fixed charge paradigm. No doubt there are individual cases that would benefit from a more sophisticated energy model or dynamical treatment, and properties other than protein-ligand binding energies may be more sensitive to these approximations. We conclude that an inflection point in the ability of MD simulations to impact drug discovery has now been attained, due to the confluence of hardware and software development along with the formulation of "good enough" theoretical methods and models.

Learning a force field from small-molecule crystal lattice predictions enables consistent sub-Angstrom protein-ligand docking

New trends in computational structure prediction of ligand-protein complexes for receptor-based drug design

Identifying ligand binding sites and poses using GPU-accelerated Hamiltonian replica exchange molecular dynamics

Advancing Drug Discovery through Enhanced Free Energy Calculations

Machine-Learned Fragment-Based Energies for Crystal Structure Prediction

A Robust Induced Fit Docking Approach with the Combination of the Hybrid All-Atom/United-Atom/Coarse-Grained Model and Simulated Annealing

Docking guidance with experimental ligand structural density improves docking pose prediction and virtual screening performance

Leveraging nonstructural data to predict structures and affinities of protein-ligand complexes

On achieving high accuracy and reliability in the calculation of relative protein–ligand binding affinities

A Robust Crystal Structure Prediction Method to Support Small Molecule Drug Development with Large Scale Validation and Prospective Studies

FitDock: protein–ligand docking by template fitting

Conformer selection and induced fit in flexible backbone protein-protein docking using computational and NMR ensembles

Accurate Calculation of Relative Binding Free Energies Between Ligands with Different Net Charges

Conformation search across multiple-level potential-energy- surfaces (CSAMP): A strategy for accurate prediction of protein-ligand binding structures.

Docking to RNA via Root-Mean-Square-Deviation-Driven Energy Minimization with Flexible Ligands and Flexible Targets

Multiple ligand simultaneous docking: Orchestrated dancing of ligands in binding sites of protein

A fully differentiable ligand pose optimization framework guided by deep learning and a traditional scoring function

CDOCKER and $$\Lambda$$-Dynamics for Prospective Prediction in D3R Grand Challenge 2

CovalentDock: Automated Covalent Docking with Parameterized Covalent Linkage Energy Estimation and Molecular Geometry Constraints.

Improved prediction of ligand-protein binding affinities by meta-modeling